Related references
Note: Only part of the references are listed.Advances in Fucoxanthin Research for the Prevention and Treatment of Inflammation-Related Diseases
Biyun Guan et al.
NUTRIENTS (2022)
Fucoxanthin: A Promising Phytochemical on Diverse Pharmacological Targets
Mumtaza Mumu et al.
FRONTIERS IN PHARMACOLOGY (2022)
The right Timing, right combination, right sequence, and right delivery for Cancer immunotherapy
Minsu Kwon et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Fucoxanthin extracted from Laminaria Japonica inhibits metastasis and enhances the sensitivity of lung cancer to Gefitinib
Jia Xiong Ming et al.
JOURNAL OF ETHNOPHARMACOLOGY (2021)
The MTT Assay: Utility, Limitations, Pitfalls, and Interpretation in Bulk and Single-Cell Analysis
Mahshid Ghasemi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Fucoxanthin and Colorectal Cancer Prevention
Masaru Terasaki et al.
CANCERS (2021)
Fucoxanthin Holds Potential to Become a Drug Adjuvant in Breast Cancer Treatment: Evidence from 2D and 3D Cell Cultures
Fernanda Malhao et al.
MOLECULES (2021)
The carotenoid fucoxanthin can sensitize multidrug resistant cancer cells to doxorubicin via induction of apoptosis, inhibition of multidrug resistance proteins and metabolic enzymes
Safaa Yehia Eid et al.
PHYTOMEDICINE (2020)
Carotenoids in Cancer Apoptosis-The Road from Bench to Bedside and Back
Lenka Koklesova et al.
CANCERS (2020)
Fucoidan from marine brown algae attenuates pancreatic cancer progression by regulating p53-NFκB crosstalk
Caroline R. Delma et al.
PHYTOCHEMISTRY (2019)
Comparison of chemical profile and antioxidant properties of the brown algae
Thanh T. Dang et al.
INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY (2018)
Investigation of the Anti-Prostate Cancer Properties of Marine-Derived Compounds
Meiqi Fan et al.
MARINE DRUGS (2018)
Toxicological assessment of Xanthigen (R) nutraceutical extract combination: Mutagenicity, genotoxicity and oral toxicity
L. Lopez-Rios et al.
TOXICOLOGY REPORTS (2018)
Carotenoids: biochemistry, pharmacology and treatment
Alireza Milani et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Gemcitabine inhibits proliferation and induces apoptosis in human pancreatic cancer PANC-1 cells
Gui Yong-Xian et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2016)
Profiling ribonucleotide and deoxyribonucleotide pools perturbed by gemcitabine in human non-small cell lung cancer cells
Jian-Ru Guo et al.
SCIENTIFIC REPORTS (2016)
MIA PaCa-2 and PANC-1-pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors
Rui Gradiz et al.
SCIENTIFIC REPORTS (2016)
Fucoxanthin: A Promising Medicinal and Nutritional Ingredient
Hui Zhang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)
Fucoxanthin and Its Metabolite Fucoxanthinol in Cancer Prevention and Treatment
Luc J. Martin
MARINE DRUGS (2015)
Anti-Obesity Activity of the Marine Carotenoid Fucoxanthin
Maria Alessandra Gammone et al.
MARINE DRUGS (2015)
Targeting the Mitotic Catastrophe Signaling Pathway in Cancer
Margaret M. Mc Gee
MEDIATORS OF INFLAMMATION (2015)
Addressing the challenges of pancreatic cancer: Future directions for improving outcomes
Manuel Hidalgo et al.
PANCREATOLOGY (2015)
Bioactive compounds from brown seaweeds: Phloroglucinol, fucoxanthin and fucoidan as promising therapeutic agents against breast cancer
D. Padua et al.
PHYTOCHEMISTRY LETTERS (2015)
Anticancer effects of fucoxanthin and fucoxanthinol on colorectal cancer cell lines and colorectal cancer tissues
Kazuto Takahashi et al.
ONCOLOGY LETTERS (2015)
Enhanced breast cancer therapy with nsPEFs and low concentrations of gemcitabine
Shan Wu et al.
CANCER CELL INTERNATIONAL (2014)
Glaucarubinone and gemcitabine synergistically reduce pancreatic cancer growth via down-regulation of P21-activated kinases
Dannel Yeo et al.
CANCER LETTERS (2014)
First-Line Gemcitabine Plus Cisplatin in Nonsmall Cell Lung Cancer Patients
Ying Li et al.
DISEASE MARKERS (2014)
BRCA2 and RAD51 Promote Double-Strand Break Formation and Cell Death in Response to Gemcitabine
Rebecca M. Jones et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Anticancer and Antitumor Potential of Fucoidan and Fucoxanthin, Two Main Metabolites Isolated from Brown Algae
Soheil Zorofchian Moghadamtousi et al.
SCIENTIFIC WORLD JOURNAL (2014)
Extracts from New Zealand Undaria pinnatifida Containing Fucoxanthin as Potential Functional Biomaterials against Cancer in Vitro
Sheng Kelvin Wang et al.
JOURNAL OF FUNCTIONAL BIOMATERIALS (2014)
Sensitization of human cancer cells to gemcitabine by the Chk1 inhibitor MK-8776: cell cycle perturbation and impact of administration schedule in vitro and in vivo
Ryan Montano et al.
BMC CANCER (2013)
Role of radiation therapy in the management of pancreatic cancer
Karyn A. Goodman et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Combination chemotherapy of nafamostat mesylate with gemcitabine for gallbladder cancer targeting nuclear factor-κB activation
Ryota Iwase et al.
JOURNAL OF SURGICAL RESEARCH (2013)
Fucoxanthin Enhances Cisplatin-Induced Cytotoxicity via NFκB-Mediated Pathway and Downregulates DNA Repair Gene Expression in Human Hepatoma HepG2 Cells
Cheng-Ling Liu et al.
MARINE DRUGS (2013)
Fucoxanthin: A Marine Carotenoid Exerting Anti-Cancer Effects by Affecting Multiple Mechanisms
Sangeetha Ravi Kumar et al.
MARINE DRUGS (2013)
Lycopene and Beta-Carotene Induce Growth Inhibition and Proapoptotic Effects on ACTH-Secreting Pituitary Adenoma Cells
Natalia F. Haddad et al.
PLOS ONE (2013)
Anti-Pancreatic Cancer Deliverables from Sea: First-Hand Evidence on the Efficacy, Molecular Targets and Mode of Action for Multifarious Polyphenols from Five Different Brown-Algae
Sheeja Aravindan et al.
PLOS ONE (2013)
Pharmacokinetics of fucoxanthinol in human plasma after the oral administration of kombu extract
Takashi Hashimoto et al.
BRITISH JOURNAL OF NUTRITION (2012)
Molecular evidence for increased antitumor activity of gemcitabine in combination with a cyclin-dependent kinase inhibitor, P276-00 in pancreatic cancers
Maggie J. Rathos et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Pancreatic cancer: Overview of descriptive epidemiology
Cristina Bosetti et al.
MOLECULAR CARCINOGENESIS (2012)
Carotenoids reverse multidrug resistance in cancer cells by interfering with ABC-transporters
Safaa Yehia Eid et al.
PHYTOMEDICINE (2012)
Interaction of an amphiphilic squalenoyl prodrug of gemcitabine with cellular membranes
L. Bildstein et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2011)
Effects of fucoxanthin on proliferation and apoptosis in human gastric adenocarcinoma MGC-803 cells via JAK/STAT signal pathway
Rui-xue Yu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Fucoxanthin, a Marine Carotenoid Present in Brown Seaweeds and Diatoms: Metabolism and Bioactivities Relevant to Human Health
Juan Peng et al.
MARINE DRUGS (2011)
Protective effects of fucoxanthin against ferric nitrilotriacetate-induced oxidative stress in murine hepatic BNL CL.2 cells
Cheng-Ling Liu et al.
TOXICOLOGY IN VITRO (2011)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer
Jennifer P. Morton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Single and repeated oral dose toxicity study of fucoxanthin (FX), a marine carotenoid, in mice
Fumiaki Beppu et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2009)
In vitro and in vivo evaluation of mutagenicity of fucoxanthin (FX) and its metabolite fucoxanthinol (FXOH)
Fumiaki Beppu et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2009)
Antiadult T-cell leukemia effects of brown algae fucoxanthin and its deacetylated product, fucoxanthinol
Chie Ishikawa et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
The antioxidant effect exerted by TGF-1β-stimulated hyaluronan production reduced NF-kB activation and apoptosis in human fibroblasts exposed to FeSo4 plus ascorbate
Giuseppe M. Campo et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
Discontinuous fragmentation of nuclear DNA during apoptosis revealed by discrete sub-G1 peaks on DNA content histograms
Malgorzata Kajstura et al.
CYTOMETRY PART A (2007)
Effect of gemcitabine on the expression of a poptosis-related genes in human pancreatic cancer cells
Pei-Hong Jiang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Fucoxanthin induces cell cycle arrest at G0/G1 phase in human colon carcinoma cells through up-regulation of p21WAF1/Cip1
SK Das et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2005)
Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells
G Bocci et al.
BRITISH JOURNAL OF CANCER (2005)
Cancer prevention by retinoids and carotenoids: Independent action on a common target
JS Bertram et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity - Evidence that mitotic Bcl-2 phosphorylation is JNK-independent
LH Du et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Biotransformation of fucoxanthinol into amarouciaxanthin A in mice and HepG2 cells: Formation and cytotoxicity of fucoxanthin metabolites
A Asai et al.
DRUG METABOLISM AND DISPOSITION (2004)
Gemcitabine activity in cervical cancer cell lines
P Hernández et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2001)
Pre-clinical evaluation of the activity of gemcitabine as a basis for regional chemotherapy of pancreatic and colorectal cancer
M Kornmann et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2000)
Share Paper
